)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
M1 Kliniken
M1 Kliniken (M12) investor relations material
M1 Kliniken Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary9 Sep, 2026
Executive summary
Completed strategic realignment to focus exclusively on high-margin aesthetic medicine after selling HAEMATO Pharm GmbH as of 31 January 2026, making prior-year comparisons limited.
Beauty segment revenue grew 11.0% year-over-year to EUR 56.9 million, with EBIT up 23.8% to EUR 18.6 million and EBIT margin improving to 32.7%.
Group turnover dropped to EUR 76.6 million from EUR 183.5 million due to the divestiture, but EBIT margin more than doubled to 20.4%.
Adjusted EBIT (excluding one-off deconsolidation effect) was EUR 19.7 million, 9.5% above the previous year.
Dividend of EUR 1.20 per share approved at the July 2026 AGM.
Financial highlights
Group sales for Jan-Jun 2026: EUR 76.6 million (down from EUR 183.5 million year-over-year).
EBIT: EUR 15.6 million (down from EUR 18.0 million), but EBIT margin rose to 20.4% from 9.8%.
Net income: EUR 11.3 million (down from EUR 12.5 million).
Gross profit increased 19.3% to EUR 44.5 million; gross margin improved from 20.3% to 58.1%.
Cash and cash equivalents rose to EUR 60.5 million from EUR 37.8 million at year-end 2025.
Outlook and guidance
Group turnover will be significantly lower in 2026 due to the sale of the retail division, but earnings quality is structurally improved.
Beauty segment expected to see significant year-on-year growth in 2026, driven by higher utilisation and new centre openings.
Medium-term target: annual turnover of EUR 200–300 million in Beauty segment with sustainable EBIT margin of at least 20%.
Plans to expand national and international clinics to drive profitable growth and global market leadership in aesthetic medicine.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from M1 Kliniken
- Beauty segment EBIT up 37.6% year-over-year; group refocused on high-margin aesthetic medicine.M12
Q1 2026 - Strong EBIT and EPS growth, Beauty segment milestone, and strategic expansion drive results.M12H2 2025
- Net profit rose 52.5% on 7.2% higher revenue, with strong growth in the Beauty segment.M12H2 2024
- Strong H1 2025 growth in revenue, profit, and cash flow, with higher margins and dividend payout.M12H1 2025
- Robust profit growth and strategic expansion reinforce global ambitions in medical aesthetics.M12Q3 2025
- EBIT up 71% and net profit up 247% year-over-year, driven by Beauty segment growth.M12Q3 2024
- EBIT nearly doubled and Beauty segment sales soared, fueling robust growth and expansion.M12H1 2024
- Net profit surged 65% to €11.7m on double-digit sales growth and margin expansion.M12H2 2023
- EBIT surged 70% in Q1 2024 as Beauty segment sales and margins hit new highs.M12Q1 2024
Next M1 Kliniken earnings date
Q3 202610 Dec, 2026
M1 Kliniken
Next M1 Kliniken earnings date
Q3 202610 Dec, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
M1 Kliniken AG is a prominent provider of beauty medical health services in Germany, specializing in the aesthetic and surgical field. The company operates under the brand "M1 Med Beauty" across more than 35 specialist centres, offering a wide range of beauty medical treatments. The company's services extend to liposuction, eyebrow lifting, wrinkle and lip treatments, and tummy tuck surgery among other aesthetic and surgical treatment services. The company is headquartered in Berlin, Germany, and its shares are listed on the ETR.